JY

John M. Yanni

AP Arrowhead Pharmaceuticals: 2 patents #4 of 34Top 15%
Overall (2017): #137,189 of 506,227Top 30%
2
Patents 2017

Issued Patents 2017

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
9765340 RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller 2017-09-19
9745585 RNAi-mediated inhibition of histamine receptor H1-related conditions Jon E. Chatterton, Daniel A. Gamache, Steven T. Miller 2017-08-29